Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

American Well Corp Cl A (AMWL)

American Well Corp Cl A (AMWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 87,395
  • Shares Outstanding, K 16,552
  • Annual Sales, $ 249,330 K
  • Annual Income, $ -95,700 K
  • EBIT $ -71 M
  • EBITDA $ -34 M
  • 60-Month Beta 1.34
  • Price/Sales 0.37
  • Price/Cash Flow N/A
  • Price/Book 0.37

Options Overview Details

View History
  • Implied Volatility 88.29% (+8.45%)
  • Historical Volatility 82.79%
  • IV Percentile 38%
  • IV Rank 13.80%
  • IV High 247.25% on 11/10/25
  • IV Low 62.84% on 08/14/25
  • Expected Move (DTE 19) 0.94 (17.71%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 73
  • Volume Avg (30-Day) 134
  • Put/Call OI Ratio 1.48
  • Today's Open Interest 1,507
  • Open Int (30-Day) 2,626
  • Expected Range 4.35 to 6.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.77
  • Number of Estimates 1
  • High Estimate -0.77
  • Low Estimate -0.77
  • Prior Year -1.73
  • Growth Rate Est. (year over year) +55.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.94 +6.88%
on 03/03/26
6.04 -12.58%
on 03/13/26
-0.42 (-7.37%)
since 02/27/26
3-Month
4.10 +28.78%
on 02/03/26
6.04 -12.58%
on 03/13/26
+0.73 (+16.04%)
since 12/26/25
52-Week
3.71 +42.32%
on 11/21/25
9.15 -42.30%
on 06/30/25
-2.81 (-34.73%)
since 03/27/25

Most Recent Stories

More News
Amwell® to Participate in Upcoming Investor Conference

BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark...

AMWL : 5.28 (-4.17%)
Amwell makes grant to new employee under inducement plan

BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announced that on February...

AMWL : 5.28 (-4.17%)
Amwell® Announces Results for Fourth Quarter and Full Year 2025

BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial...

AMWL : 5.28 (-4.17%)
Amwell® to report fourth quarter and full year 2025 operating results

BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report fourth quarter...

AMWL : 5.28 (-4.17%)
Amwell® Announces Results for Third Quarter 2025

BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial...

AMWL : 5.28 (-4.17%)
Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences

BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report third quarter...

AMWL : 5.28 (-4.17%)
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy?

Virtual healthcare is rapidly evolving, with Hims & Hers Health, Inc. HIMS and American Well Corporation AMWL, popularly known as Amwell, at the forefront. HIMS is a consumer-focused digital health platform...

HIMS : 19.38 (-7.09%)
AMWL : 5.28 (-4.17%)
Amwell makes grant to new employees under inducement plan

BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate...

AMWL : 5.28 (-4.17%)
Amwell® Announces Results for Second Quarter 2025

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the...

AMWL : 5.28 (-4.17%)
Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extension...

AMWL : 5.28 (-4.17%)

Business Summary

American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 5.64
2nd Resistance Point 5.55
1st Resistance Point 5.42
Last Price 5.28
1st Support Level 5.20
2nd Support Level 5.11
3rd Support Level 4.98

See More

52-Week High 9.15
Fibonacci 61.8% 7.07
Fibonacci 50% 6.43
Fibonacci 38.2% 5.79
Last Price 5.28
52-Week Low 3.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.